TOP NEWS

Abraxis Bioscience Buys Manufacturing Complex From Pfizer

Los Angeles-based Abraxis BioScience said this week that it has completed the acquisition of a manufacturing facility in Puerto Rico from Pfizer. The firm, which develops products for the oncology, infectious disease, and critical care healthcare areas, said that the 56-acre site includes 172,000 square feet of manufacturing capabilities for injectable pharmaceuticals. The firm will begin commercial manufacturing from the site in the first half of 2007.


LATEST HEADLINES

More Headlines

BROWSE ISSUES